CRISPR

Monsanto gains access to ToolGen CRISPR platform

· August 17, 2017

Monsanto and ToolGen, a biotechnology company specializing in genome editing, have reached a global licensing agreement for the use of ToolGen’s CRISPR technology platform to develop agricultural products. ToolGen is an early pioneer in gene editing research. The license provides Monsanto with access to ToolGen’s comprehensive suite of CRISPR intellectual property for use in plants. […]

Monsanto adds latest genome-editing tech to portfolio

· January 4, 2017

Monsanto will have access to an updated genome-editing technology after signing a global licensing agreement with the Broad Institute of MIT and Harvard for the use of CRISPR-Cpf1 in agriculture. The CRISPR-Cpf1 system has potential to be a simpler and more precise tool for making targeted improvements in a cell’s DNA when compared to the […]

Monsanto captures CRISPR

· September 22, 2016

A genome-editing technology that revolutionized the food science industry when it came out on the market in 2012 will now be part of Monsanto’s R&D. The leading global seed supplier recently announced that they grabbed the global licensing rights for the use of the CRISPR-Cas genome-editing technology in agriculture with the Broad Institute of MIT and […]

Load more